Cargando…

GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A Streptococcus

Group A Streptococcus (GAS) causes about 500,000 annual deaths globally, and no vaccines are currently available. The Group A Carbohydrate (GAC), conserved across all GAS serotypes, conjugated to an appropriate carrier protein, represents a promising vaccine candidate. Here, we explored the possibil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palmieri, Elena, Kis, Zoltán, Ozanne, James, Di Benedetto, Roberta, Ricchetti, Beatrice, Massai, Luisa, Carducci, Martina, Oldrini, Davide, Gasperini, Gianmarco, Aruta, Maria Grazia, Rossi, Omar, Kontoravdi, Cleo, Shah, Nilay, Mawas, Fatme, Micoli, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324507/ https://www.ncbi.nlm.nih.gov/pubmed/35891202 http://dx.doi.org/10.3390/vaccines10071034

Ejemplares similares

GMMA and Glycoconjugate Approaches Compared in Mice for the Development of a Vaccine against Shigella flexneri Serotype 6
por: Raso, Maria Michelina, et al.
Publicado: (2020)

Comparison of Shigella GMMA and glycoconjugate four-component formulations in animals
por: Di Benedetto, Roberta, et al.
Publicado: (2023)

Rational Design of a Glycoconjugate Vaccine against Group A Streptococcus
por: Di Benedetto, Roberta, et al.
Publicado: (2020)

Novel Simple Conjugation Chemistries for Decoration of GMMA with Heterologous Antigens
por: Di Benedetto, Roberta, et al.
Publicado: (2021)

Effect of O-Antigen Chain Length Regulation on the Immunogenicity of Shigella and Salmonella Generalized Modules for Membrane Antigens (GMMA)
por: Gasperini, Gianmarco, et al.
Publicado: (2021)

GMMA Is a Versatile Platform to Design Effective Multivalent Combination Vaccines
por: Micoli, Francesca, et al.
Publicado: (2020)

Dissecting the contribution of O-Antigen and proteins to the immunogenicity of Shigella sonnei generalized modules for membrane antigens (GMMA)
por: Mancini, Francesca, et al.
Publicado: (2021)

Rapid generation of Shigella flexneri GMMA displaying natural or new and cross-reactive O-Antigens
por: Gasperini, Gianmarco, et al.
Publicado: (2022)

Progress towards a glycoconjugate vaccine against Group A Streptococcus
por: Burns, Keira, et al.
Publicado: (2023)

Exploring the Role of GMMA Components in the Immunogenicity of a 4-Valent Vaccine against Shigella
por: Mancini, Francesca, et al.
Publicado: (2023)

Impact of O-Acetylation on S. flexneri 1b and 2a O-Antigen Immunogenicity in Mice
por: Arato, Vanessa, et al.
Publicado: (2021)

Neisseria meningitidis Factor H Binding Protein Surface Exposure on Salmonella Typhimurium GMMA Is Critical to Induce an Effective Immune Response against Both Diseases
por: Necchi, Francesca, et al.
Publicado: (2021)

A next-generation GMMA-based vaccine candidate to fight shigellosis
por: Rossi, Omar, et al.
Publicado: (2023)

Generalized Modules for Membrane Antigens (GMMA), an outer membrane vesicle‐based vaccine platform, for efficient viral antigen delivery
por: Hu, Kai, et al.
Publicado: (2022)

Multicomponent Vaccines against Group A Streptococcus Can Effectively Target Broad Disease Presentations
por: Shaw, Helen A., et al.
Publicado: (2021)

Stability of Outer Membrane Vesicles-Based Vaccines, Identifying the Most Appropriate Methods to Detect Changes in Vaccine Potency
por: Palmieri, Elena, et al.
Publicado: (2021)

Characterization of Competitive ELISA and Formulated Alhydrogel Competitive ELISA (FAcE) for Direct Quantification of Active Ingredients in GMMA-Based Vaccines
por: Rossi, Omar, et al.
Publicado: (2020)

GMMA-Based Vaccines: The Known and The Unknown
por: Mancini, Francesca, et al.
Publicado: (2021)

Towards a Four-Component GMMA-Based Vaccine against Shigella
por: Micoli, Francesca, et al.
Publicado: (2022)

Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand
por: Kis, Zoltán, et al.
Publicado: (2020)

Correction: Kis, Z. et al. Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand. Vaccines 2021, 9, 3
por: Kis, Zoltán, et al.
Publicado: (2021)

Generalized Modules for Membrane Antigens as Carrier for Polysaccharides: Impact of Sugar Length, Density, and Attachment Site on the Immune Response Elicited in Animal Models
por: Micoli, Francesca, et al.
Publicado: (2021)

Protein Carriers for Glycoconjugate Vaccines: History, Selection Criteria, Characterization and New Trends
por: Micoli, Francesca, et al.
Publicado: (2018)

Rapid development and deployment of high‐volume vaccines for pandemic response
por: Kis, Zoltán, et al.
Publicado: (2020)

Development of a Monocyte Activation Test as an Alternative to the Rabbit Pyrogen Test for Mono- and Multi-Component Shigella GMMA-Based Vaccines
por: Carson, Danielle, et al.
Publicado: (2021)

Investigating the Role of Antigen Orientation on the Immune Response Elicited by Neisseria meningitidis Factor H Binding Protein on GMMA
por: Alfini, Renzo, et al.
Publicado: (2022)

Impact and Control of Sugar Size in Glycoconjugate Vaccines
por: Stefanetti, Giuseppe, et al.
Publicado: (2022)

Dissecting in Vitro the Activation of Human Immune Response Induced by Shigella sonnei GMMA
por: Tondi, Serena, et al.
Publicado: (2022)

Potential targets for next generation antimicrobial glycoconjugate vaccines
por: Micoli, Francesca, et al.
Publicado: (2018)

Optimal design and planning of supply chains for viral vectors and RNA vaccines
por: Ibrahim, Dauda, et al.
Publicado: (2022)

Pandemic-response adenoviral vector and RNA vaccine manufacturing
por: Kis, Zoltán, et al.
Publicado: (2022)

Model-Based Planning and Delivery of Mass Vaccination Campaigns against Infectious Disease: Application to the COVID-19 Pandemic in the UK
por: Ibrahim, Dauda, et al.
Publicado: (2021)

Antibodies Elicited by the Shigella sonnei GMMA Vaccine in Adults Trigger Complement-Mediated Serum Bactericidal Activity: Results From a Phase 1 Dose Escalation Trial Followed by a Booster Extension
por: Micoli, Francesca, et al.
Publicado: (2021)

Modelling of amorphous cellulose depolymerisation by cellulases, parametric studies and optimisation
por: Niu, Hongxing, et al.
Publicado: (2016)

Click chemistry compared to thiol chemistry for the synthesis of site-selective glycoconjugate vaccines using CRM(197) as carrier protein
por: Stefanetti, G., et al.
Publicado: (2020)

Mucosal Immunization Has Benefits over Traditional Subcutaneous Immunization with Group A Streptococcus Antigens in a Pilot Study in a Mouse Model
por: Shaw, Helen Alexandra, et al.
Publicado: (2023)

Increasing the High Throughput of a Luminescence-Based Serum Bactericidal Assay (L-SBA)
por: Aruta, Maria Grazia, et al.
Publicado: (2021)

The influence of conjugation variables on the design and immunogenicity of a glycoconjugate vaccine against Salmonella Typhi
por: Arcuri, M., et al.
Publicado: (2017)

Exploring the variables influencing the immune response of traditional and innovative glycoconjugate vaccines
por: Micoli, Francesca, et al.
Publicado: (2023)

Enhanced Systemic Humoral Immune Response Induced in Mice by Generalized Modules for Membrane Antigens (GMMA) Is Associated with Affinity Maturation and Isotype Switching
por: Piccioli, Diego, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d0d92ge3g4ecrf9b7ssk8rt828